Ng\u00e0y 13 th\u00e1ng 9 l\u00e0 Ng\u00e0y Th\u1ebf gi\u1edbi ph\u00f2ng ch\u1ed1ng nhi\u1ec5m tr\u00f9ng huy\u1ebft (World Sepsis Day), m\u1ed9t s\u1ef1 ki\u1ec7n to\u00e0n c\u1ea7u nh\u1eb1m n\u00e2ng cao nh\u1eadn th\u1ee9c v\u1ec1 m\u1ed9t t\u00ecnh tr\u1ea1ng nguy hi\u1ec3m v\u00e0 th\u01b0\u1eddng g\u00e2y t\u1eed vong. T\u1ea1i khu v\u1ef1c Ch\u00e2u \u00c1 \u2013 Th\u00e1i B\u00ecnh D\u01b0\u01a1ng, nhu c\u1ea7u c\u1ea3i thi\u1ec7n ch\u0103m s\u00f3c nhi\u1ec5m tr\u00f9ng huy\u1ebft \u2014 bao g\u1ed3m c\u00e1c ph\u01b0\u01a1ng ph\u00e1p ch\u1ea9n \u0111o\u00e1n ch\u1ea5t l\u01b0\u1ee3ng cao \u0111\u1ec3 gi\u00fap x\u00e1c \u0111\u1ecbnh v\u00e0 x\u1eed l\u00fd t\u00ecnh tr\u1ea1ng n\u00e0y \u2014 \u0111\u1eb7c bi\u1ec7t c\u1ea5p b\u00e1ch.<\/p>\n
Tr\u00ean to\u00e0n c\u1ea7u, c\u00f3 \u0111\u1ebfn 50 tri\u1ec7u ng\u01b0\u1eddi b\u1ecb nhi\u1ec5m tr\u00f9ng huy\u1ebft m\u1ed7i n\u0103m, v\u1edbi h\u01a1n 11 tri\u1ec7u ca t\u1eed vong. \u1ede khu v\u1ef1c ch\u00e2u \u00c1 Th\u00e1i B\u00ecnh D\u01b0\u01a1ng, t\u1ef7 l\u1ec7 t\u1eed vong cao t\u1edbi 35% \u2014 cao h\u01a1n \u0111\u00e1ng k\u1ec3 so v\u1edbi \u1edf h\u1ea7u h\u1ebft c\u00e1c qu\u1ed1c gia c\u00f3 thu nh\u1eadp cao [1]. \u0110i\u1ec1u \u0111\u00f3 li\u00ean quan \u0111\u1ebfn vi\u1ec7c ti\u1ebfp c\u1eadn h\u1ea1n ch\u1ebf v\u1edbi d\u1ecbch v\u1ee5 ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe ch\u1ea5t l\u01b0\u1ee3ng cao, bao g\u1ed3m c\u00e1c ph\u01b0\u01a1ng ph\u00e1p ch\u1ea9n \u0111o\u00e1n \u0111\u00e1ng tin c\u1eady c\u1ea7n thi\u1ebft cho ph\u00e1t hi\u1ec7n s\u1edbm, c\u0169ng nh\u01b0 nh\u1eadn th\u1ee9c th\u1ea5p v\u1ec1 nhi\u1ec5m tr\u00f9ng huy\u1ebft v\u00e0 m\u1ee9c \u0111\u1ed9 nguy hi\u1ec3m c\u1ee7a n\u00f3.<\/p>\n
M\u1ed9t s\u1ed1 n\u01a1i \u1edf ch\u00e2u \u00c1 ch\u1ecbu \u1ea3nh h\u01b0\u1edfng \u0111\u1eb7c bi\u1ec7t cao t\u1eeb c\u0103n b\u1ec7nh n\u00e0y. V\u00ed d\u1ee5, \u1edf \u1ea4n \u0110\u1ed9, m\u1ed9t nghi\u00ean c\u1ee9u cho th\u1ea5y h\u01a1n m\u1ed9t n\u1eeda s\u1ed1 b\u1ec7nh nh\u00e2n \u0111ang \u0111\u01b0\u1ee3c \u0111i\u1ec1u tr\u1ecb t\u1ea1i c\u00e1c \u0111\u01a1n v\u1ecb ch\u0103m s\u00f3c \u0111\u1eb7c bi\u1ec7t b\u1ecb nhi\u1ec5m tr\u00f9ng huy\u1ebft [2]. Ch\u1eafc ch\u1eafn l\u00e0 c\u00e1c n\u01b0\u1edbc c\u00f3 ngu\u1ed3n l\u1ef1c th\u1ea5p kh\u00e1c c\u0169ng \u0111ang ph\u1ea3i \u0111\u1ed1i m\u1eb7t v\u1edbi nh\u1eefng kh\u00f3 kh\u0103n t\u01b0\u01a1ng t\u1ef1. V\u1eady ch\u00fang ta c\u1ea7n l\u00e0m g\u00ec?<\/p>\n
Nhi\u1ec5m tr\u00f9ng huy\u1ebft l\u00e0 k\u1ebft qu\u1ea3 c\u1ee7a ph\u1ea3n \u1ee9ng kh\u00f4ng ki\u1ec3m so\u00e1t \u0111\u01b0\u1ee3c \u0111\u1ed1i v\u1edbi nhi\u1ec5m tr\u00f9ng: ph\u1ea3n \u1ee9ng vi\u00eam x\u1ea3y ra r\u1ed1i lo\u1ea1n v\u00e0 c\u00f3 th\u1ec3 \u0111e d\u1ecda t\u00ednh m\u1ea1ng. T\u00ecnh tr\u1ea1ng n\u00e0y th\u01b0\u1eddng li\u00ean quan \u0111\u1ebfn c\u00e1c nhi\u1ec5m tr\u00f9ng \u1edf ph\u1ed5i, da, \u0111\u01b0\u1eddng ti\u00eau ho\u00e1 ho\u1eb7c \u0111\u01b0\u1eddng ti\u1ebft ni\u1ec7u v\u00e0 g\u1eb7p nhi\u1ec1u nh\u1ea5t \u1edf tr\u1ebb s\u01a1 sinh, ng\u01b0\u1eddi cao tu\u1ed5i, v\u00e0 nh\u1eefng ng\u01b0\u1eddi m\u1eafc b\u1ec7nh m\u1ea1n t\u00ednh ho\u1eb7c c\u00f3 h\u1ec7 mi\u1ec5n d\u1ecbch suy gi\u1ea3m.<\/p>\n
V\u00ec sao vi\u1ec7c n\u00e2ng cao nh\u1eadn th\u1ee9c v\u1ec1 nhi\u1ec5m tr\u00f9ng huy\u1ebft l\u1ea1i quan tr\u1ecdng \u0111\u1ebfn v\u1eady? V\u00ec t\u00ecnh tr\u1ea1ng n\u00e0y nh\u1ea1y c\u1ea3m v\u1edbi th\u1eddi gian b\u1ea5t th\u01b0\u1eddng n\u00ean vi\u1ec7c bi\u1ebft \u0111\u01b0\u1ee3c c\u00e1c d\u1ea5u hi\u1ec7u v\u00e0 h\u00e0nh \u0111\u1ed9ng nhanh ch\u00f3ng c\u00f3 th\u1ec3 gi\u00fap c\u1ee9u s\u1ed1ng m\u1ea1ng ng\u01b0\u1eddi. C\u00e1c nh\u00e0 khoa h\u1ecdc \u0111\u00e3 ph\u00e1t hi\u1ec7n ra r\u1eb1ng trong 12 gi\u1edd ch\u0103m s\u00f3c \u0111\u1ea7u ti\u00ean cho m\u1ed9t b\u1ec7nh nh\u00e2n b\u1ecb nhi\u1ec5m tr\u00f9ng huy\u1ebft, m\u1ed7i l\u1ea7n tr\u00ec ho\u00e3n n\u0103m ph\u00fat trong qu\u00e1 tr\u00ecnh \u0111i\u1ec1u tr\u1ecb th\u00edch h\u1ee3p s\u1ebd l\u00e0m t\u0103ng t\u1ef7 l\u1ec7 t\u1eed vong kho\u1ea3ng 1% [3]. \u0110i\u1ec1u \u0111\u00f3 c\u00f3 ngh\u0129a l\u00e0 kh\u00f4ng ch\u1ec9 c\u00e1c b\u00e1c s\u0129 v\u00e0 \u0111\u1ed9i ng\u0169 ph\u00f2ng x\u00e9t nghi\u1ec7m l\u00e2m s\u00e0ng c\u1ea7n ph\u1ea3i hi\u1ec3u r\u00f5 v\u1ec1 nhi\u1ec5m tr\u00f9ng huy\u1ebft, m\u00e0 vi\u1ec7c n\u00e2ng cao nh\u1eadn th\u1ee9c trong c\u1ed9ng \u0111\u1ed3ng n\u00f3i chung c\u0169ng l\u00e0 v\u00f4 c\u00f9ng c\u1ea7n thi\u1ebft.<\/p>\n
Th\u1eadt kh\u00f4ng may, vi\u1ec7c ph\u00e1t hi\u1ec7n s\u1edbm r\u1ea5t ph\u1ee9c t\u1ea1p b\u1edfi c\u00e1c tri\u1ec7u ch\u1ee9ng kh\u00f4ng \u0111\u1eb7c hi\u1ec7u do nhi\u1ec5m tr\u00f9ng huy\u1ebft g\u00e2y ra. M\u1ed9t b\u1ec7nh nh\u00e2n c\u00f3 th\u1ec3 bi\u1ec3u hi\u1ec7n c\u00e1c tri\u1ec7u ch\u1ee9ng nh\u01b0: s\u1ed1t cao ho\u1eb7c th\u00e2n nhi\u1ec7t th\u1ea5p b\u1ea5t th\u01b0\u1eddng; n\u00f3i kh\u00f3 ho\u1eb7c l\u00fa l\u1eabn; \u0111au d\u1eef d\u1ed9i ho\u1eb7c kh\u00f3 ch\u1ecbu; v\u00e0 l\u01b0\u1ee3ng n\u01b0\u1edbc ti\u1ec3u r\u1ea5t \u00edt ho\u1eb7c kh\u00f4ng c\u00f3, c\u00f9ng v\u1edbi nhi\u1ec1u tri\u1ec7u ch\u1ee9ng kh\u00e1c. V\u00ec nhi\u1ec5m tr\u00f9ng huy\u1ebft b\u1eaft ngu\u1ed3n t\u1eeb ph\u1ea3n \u1ee9ng v\u1edbi nhi\u1ec5m tr\u00f9ng hi\u1ec7n c\u00f3, n\u00ean c\u00e1c b\u00e1c s\u0129 r\u1ea5t d\u1ec5 nh\u1ea7m l\u1eabn c\u00e1c tri\u1ec7u ch\u1ee9ng n\u00e0y li\u00ean quan \u0111\u1ebfn nhi\u1ec5m tr\u00f9ng ho\u1eb7c nh\u1ea7m l\u1eabn ch\u00fang v\u1edbi c\u00e1c ch\u1ea9n \u0111o\u00e1n c\u00f3 th\u1ec3 kh\u00e1c.<\/p>\n
Ngo\u00e0i t\u1ef7 l\u1ec7 m\u1eafc b\u1ec7nh v\u00e0 t\u1eed vong cao, c\u00f3 m\u1ed9t l\u00fd do kh\u00e1c nhi\u1ec5m tr\u00f9ng huy\u1ebft l\u00e0 m\u1ed9t tai h\u1ecda trong h\u1ec7 th\u1ed1ng ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe: \u0111\u00f3 l\u00e0 m\u1ed9t y\u1ebfu t\u1ed1 \u0111\u00f3ng g\u00f3p \u0111\u00e1ng k\u1ec3 cho d\u1ecbch kh\u00e1ng kh\u00e1ng sinh (antimicrobial resistance, AMR) ng\u00e0y c\u00e0ng t\u0103ng. D\u00f9 c\u00f3 th\u1ec3 ch\u1ea9n \u0111o\u00e1n nhi\u1ec5m tr\u00f9ng huy\u1ebft ch\u00ednh x\u00e1c hay kh\u00f4ng, nh\u1eefng b\u1ec7nh nh\u00e2n b\u1ecb nghi ng\u1edd m\u1eafc t\u00ecnh tr\u1ea1ng n\u00e0y r\u00f5 r\u00e0ng \u0111\u1ec1u \u0111ang trong t\u00ecnh tr\u1ea1ng nguy k\u1ecbch. C\u00e1c b\u00e1c s\u0129 th\u01b0\u1eddng \u2014 v\u00e0 ho\u00e0n to\u00e0n d\u1ec5 hi\u1ec3u \u2014 ph\u1ea3n \u1ee9ng b\u1eb1ng c\u00e1ch s\u1eed d\u1ee5ng nh\u1eefng \u201cv\u0169 kh\u00ed m\u1ea1nh nh\u1ea5t\u201d c\u1ee7a h\u1ecd, k\u00ea \u0111\u01a1n c\u00e1c lo\u1ea1i kh\u00e1ng sinh ph\u1ed5 r\u1ed9ng ph\u1ed1i h\u1ee3p ngay c\u1ea3 tr\u01b0\u1edbc khi c\u00e1c x\u00e9t nghi\u1ec7m trong ph\u00f2ng th\u00ed nghi\u1ec7m c\u00f3 th\u1ec3 \u0111\u01b0a ra k\u1ebft qu\u1ea3.<\/p>\n
Vi\u1ec7c s\u1eed d\u1ee5ng qu\u00e1 m\u1ee9c c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb n\u00e0y v\u00e0 th\u1eddi gian k\u00e9o d\u00e0i trong \u0111\u00f3 ch\u00fang \u0111\u01b0\u1ee3c s\u1eed d\u1ee5ng cho b\u1ec7nh nh\u00e2n, c\u00f3 th\u1ec3 g\u00f3p ph\u1ea7n g\u00e2y ra AMR, t\u1ea1o ra t\u00e1c \u0111\u1ed9ng ti\u00eau c\u1ef1c \u1edf c\u1ea3 c\u1ea5p \u0111\u1ed9 c\u00e1 nh\u00e2n v\u00e0 x\u00e3 h\u1ed9i g\u00e2y ra m\u1ed1i \u0111e d\u1ecda nghi\u00eam tr\u1ecdng \u0111\u1ed1i v\u1edbi c\u00e1c h\u1ec7 th\u1ed1ng ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe \u1edf m\u1ecdi n\u01a1i. \u1ede ch\u00e2u \u00c1, nguy c\u01a1 t\u1eeb AMR \u0111\u1eb7c bi\u1ec7t nguy hi\u1ec3m. M\u1ed9t ph\u00e2n t\u00edch t\u1eeb \u0110\u00e1nh gi\u00e1 v\u1ec1 kh\u00e1ng kh\u00e1ng sinh d\u1ef1 \u0111o\u00e1n r\u1eb1ng s\u1ebd c\u00f3 h\u01a1n 4,7 tri\u1ec7u ca t\u1eed vong do AMR v\u00e0o n\u0103m 2050, cao h\u01a1n m\u1ed9t b\u1eadc \u0111\u1ed9 l\u1edbn so v\u1edbi s\u1ed1 ca t\u1eed vong d\u1ef1 ki\u1ebfn \u1edf ch\u00e2u \u00c2u, B\u1eafc M\u1ef9 ho\u1eb7c M\u1ef9 Latinh [4].<\/p>\n
Th\u00f4ng th\u01b0\u1eddng, ch\u1ea9n \u0111o\u00e1n nhi\u1ec5m tr\u00f9ng huy\u1ebft d\u1ef1a tr\u00ean quan s\u00e1t l\u00e2m s\u00e0ng, c\u0169ng nh\u01b0 \u0111\u00e1nh gi\u00e1 ph\u00f2ng x\u00e9t nghi\u1ec7m th\u00f4ng qua m\u1ed9t trong ba d\u1ea5u \u1ea5n sinh h\u1ecdc:<\/a> procalcitonin (PCT), interleukin 6 (IL-6) ho\u1eb7c protein ph\u1ea3n \u1ee9ng C (CRP). X\u00e9t nghi\u1ec7m PCT l\u00e0 m\u1ed9t c\u00e1ch ti\u1ebfp c\u1eadn ph\u1ed5 bi\u1ebfn \u0111\u1ec3 ph\u00e1t hi\u1ec7n nhi\u1ec5m tr\u00f9ng huy\u1ebft v\u00ec xu\u1ea5t hi\u1ec7n tr\u00ean c\u00e1c x\u00e9t nghi\u1ec7m trong v\u00f2ng hai \u0111\u1ebfn s\u00e1u gi\u1edd v\u00e0 \u0111\u1ec9nh cao kho\u1ea3ng 24 gi\u1edd khi kh\u1edfi ph\u00e1t t\u00ecnh tr\u1ea1ng [5]. C\u00f3 th\u1ec3 s\u1eed d\u1ee5ng \u0111\u1ecbnh l\u01b0\u1ee3ng PCT \u0111\u1ec3 gi\u00fap ch\u1ea9n \u0111o\u00e1n nhi\u1ec5m tr\u00f9ng huy\u1ebft, \u0111\u00e1nh gi\u00e1 m\u1ee9c \u0111\u1ed9 nghi\u00eam tr\u1ecdng c\u1ee7a b\u1ec7nh v\u00e0 d\u1ef1 \u0111o\u00e1n nhi\u1ec5m tr\u00f9ng huy\u1ebft cho c\u00e1c nhi\u1ec5m tr\u00f9ng \u0111\u01b0\u1eddng h\u00f4 h\u1ea5p d\u01b0\u1edbi.<\/p>\n M\u1ed9t l\u1ee3i \u00edch kh\u00e1c c\u1ee7a d\u1ea5u \u1ea5n sinh h\u1ecdc PCT l\u00e0\u00a0c\u0169ng c\u00f3 th\u1ec3 \u0111\u01b0\u1ee3c s\u1eed d\u1ee5ng \u0111\u1ec3 h\u01b0\u1edbng d\u1eabn l\u1ef1a ch\u1ecdn \u0111i\u1ec1u tr\u1ecb cho b\u1ec7nh nh\u00e2n nhi\u1ec5m tr\u00f9ng huy\u1ebft \u0111\u1ec3 \u0111\u1ea3m b\u1ea3o s\u1eed d\u1ee5ng kh\u00e1ng sinh th\u00edch h\u1ee3p h\u01a1n v\u00e0 tu\u00e2n th\u1ee7 c\u00e1c quy tr\u00ecnh qu\u1ea3n l\u00fd kh\u00e1ng sinh [6,7]. V\u1edbi nh\u1eefng lo ng\u1ea1i v\u1ec1 t\u00e1c \u0111\u1ed9ng c\u1ee7a AMR, ch\u00fang ta c\u00f3 th\u1ec3 th\u1ea5y s\u1ef1 h\u1ea5p th\u1ee5 l\u1edbn h\u01a1n c\u1ee7a c\u00e1c quy tr\u00ecnh n\u00e0y, ngay c\u1ea3 trong c\u00e1c m\u00f4i tr\u01b0\u1eddng c\u00f3 t\u00e0i nguy\u00ean th\u1ea5p, \u0111i\u1ec1u n\u00e0y s\u1ebd \u0111\u00f2i h\u1ecfi ph\u1ea3i c\u00f3 chi\u1ebfn l\u01b0\u1ee3c th\u1eed nghi\u1ec7m t\u1ed1t h\u01a1n.<\/p>\n IL-6 \u00edt \u0111\u1eb7c hi\u1ec7u cho nhi\u1ec5m tr\u00f9ng huy\u1ebft h\u01a1n PCT, nh\u01b0ng v\u00ec \u0111\u1ea1t \u0111\u1ec9nh s\u1edbm h\u01a1n, nhi\u1ec1u ph\u00f2ng x\u00e9t nghi\u1ec7m l\u00e2m s\u00e0ng \u0111\u00e3 b\u1eaft \u0111\u1ea7u x\u00e9t nghi\u1ec7m d\u1ea5u \u1ea5n sinh h\u1ecdc vi\u00eam t\u1ed5ng qu\u00e1t n\u00e0y \u0111\u1ec3 c\u1ed1 g\u1eafng ph\u00e1t hi\u1ec7n nhi\u1ec5m tr\u00f9ng huy\u1ebft s\u1edbm nh\u1ea5t c\u00f3 th\u1ec3. Vi\u1ec7c x\u00e9t nghi\u1ec7m IL-6 \u0111\u00e3 tr\u1edf n\u00ean ph\u1ed5 bi\u1ebfn trong \u0111\u1ea1i d\u1ecbch COVID-19; hi\u1ec7n nay, nhi\u1ec1u ph\u00f2ng x\u00e9t nghi\u1ec7m \u0111\u00e3 th\u1ea9m \u0111\u1ecbnh c\u00e1c x\u00e9t nghi\u1ec7m IL-6 c\u00f3 th\u1ec3 \u0111\u01b0\u1ee3c s\u1eed d\u1ee5ng cho ch\u1ea9n \u0111o\u00e1n nhi\u1ec5m tr\u00f9ng huy\u1ebft. Trong khi \u0111\u00f3, CRP l\u00e0 d\u1ea5u \u1ea5n sinh h\u1ecdc h\u1eefu \u00edch nh\u1ea5t \u0111\u1ec3 ch\u1ea9n \u0111o\u00e1n s\u1edbm v\u00ec kh\u00f4ng ph\u00e1t hi\u1ec7n \u0111\u01b0\u1ee3c cho \u0111\u1ebfn 12\u201348 gi\u1edd sau khi kh\u1edfi ph\u00e1t.<\/p>\n N\u1ebfu b\u1ea1n l\u00e0 b\u00e1c s\u0129 l\u00e2m s\u00e0ng \u0111i\u1ec1u tr\u1ecb b\u1ec7nh nh\u00e2n nhi\u1ec5m tr\u00f9ng huy\u1ebft, h\u00e3y c\u00e2n nh\u1eafc m\u1edf r\u1ed9ng vi\u1ec7c s\u1eed d\u1ee5ng PCT \u0111\u1ec3 h\u1ed7 tr\u1ee3 ra quy\u1ebft \u0111\u1ecbnh l\u00e2m s\u00e0ng trong kho\u1ea3ng th\u1eddi gian \u0111i\u1ec1u tr\u1ecb b\u1eb1ng kh\u00e1ng sinh. Vi\u1ec7c n\u00e0y c\u00f3 th\u1ec3 gi\u00fap gi\u1ea3m nguy c\u01a1 v\u00e0 t\u1ef7 l\u1ec7 AMR.<\/p>\n N\u1ebfu b\u1ea1n l\u00e0m vi\u1ec7c trong m\u1ed9t ph\u00f2ng x\u00e9t nghi\u1ec7m l\u00e2m s\u00e0ng, b\u1ea1n c\u00f3 th\u1ec3 gi\u00fap n\u00e2ng cao nh\u1eadn th\u1ee9c v\u1ec1 nhi\u1ec5m tr\u00f9ng huy\u1ebft theo m\u1ed9t s\u1ed1 c\u00e1ch \u0111\u1ec3 mang \u0111\u1ebfn cho b\u1ec7nh nh\u00e2n c\u01a1 h\u1ed9i s\u1ed1ng s\u00f3t cao h\u01a1n. Sau \u0111\u00e2y l\u00e0 m\u1ed9t v\u00e0i v\u00ed d\u1ee5:<\/p>\n Th\u00e1ng 9 l\u00e0 Th\u00e1ng nh\u1eadn th\u1ee9c v\u1ec1 nhi\u1ec5m tr\u00f9ng huy\u1ebft v\u00e0 nh\u1eb1m gi\u00fap n\u00e2ng cao nh\u1eadn th\u1ee9c v\u1ec1 gi\u00e1 tr\u1ecb c\u1ee7a c\u00e1c d\u1ea5u \u1ea5n sinh h\u1ecdc \u0111\u1ec3 qu\u1ea3n l\u00fd t\u1ed1t h\u01a1n nhi\u1ec5m tr\u00f9ng huy\u1ebft, Roche Diagnostics Ch\u00e2u \u00c1 Th\u00e1i B\u00ecnh D\u01b0\u01a1ng s\u1ebd t\u1ed5 ch\u1ee9c m\u1ed9t h\u1ed9i th\u1ea3o tr\u00ean web s\u1eafp t\u1edbi, qu\u1ea3n l\u00fd kh\u00e1ng khu\u1ea9n d\u1ef1a tr\u00ean Procalcitonin (PCT), v\u00e0o ng\u00e0y 28 th\u00e1ng 9. Nh\u1ea5p v\u00e0o \u0111\u00e2y<\/a> \u0111\u1ec3 \u0111\u0103ng k\u00fd v\u00e0 t\u00ecm hi\u1ec3u th\u00eam.<\/em><\/p>\n \u0110\u1ec3 t\u00ecm hi\u1ec3u th\u00eam v\u1ec1 c\u00e1ch ch\u00fang t\u00f4i \u0111ang n\u00e2ng cao ti\u00eau chu\u1ea9n ch\u0103m s\u00f3c nhi\u1ec5m tr\u00f9ng huy\u1ebft trong khu v\u1ef1c, h\u00e3y li\u00ean h\u1ec7 v\u1edbi Stijn Vullinghs, Gi\u00e1m \u0111\u1ed1c Khu v\u1ef1c Th\u01b0\u01a1ng m\u1ea1i & B\u1ec7nh t\u1eadt v\u1ec1 nhi\u1ec5m tr\u00f9ng huy\u1ebft, t\u1ea1i stijn.vullinghs@roche.com.<\/em><\/p>\n T\u00e0i li\u1ec7u tham kh\u1ea3o:<\/p>\n [1]<\/a>\u00a0\u00a0Asia Pacific Sepsis Alliance. Truy c\u1eadp: https:\/\/www.asiapacificsepsisalliance.org\/sepsis.<\/em><\/p>\n [2]<\/a>\u00a0Sepsis claims more lives in India than in other South Asian countries. here\u2019s all you need to know about the disease (2023) Hindustan Times. Truy c\u1eadp: https:\/\/www.hindustantimes.com\/lifestyle\/health\/sepsis-claims-more-lives-in-india-than-in-other-south-asian-countries-here-s-all-you-need-to-know-about-the-disease-101673665488600.html.<\/em><\/p>\n [3]<\/a>\u00a0Funk, D.J. and Kumar, A. (2011) \u2018Antimicrobial therapy for life-threatening infections: Speed is life\u2019, Critical Care Clinics, 27(1), pp. 53\u201376. doi:10.1016\/j.ccc.2010.09.008.<\/p>\n [4]<\/a>\u00a0Antimicrobial resistance: Tackling a crisis for the health and wealth of nations. Truy c\u1eadp: https:\/\/amr-review.org\/sites\/default\/files\/AMR%20Review%20Paper%20-%20Tackling%20a%20crisis%20for%20the%20health%20and%20wealth%20of%20nations_1.pdf\u00a0<\/em><\/p>\n [5]<\/a>\u00a0Reinhart, K. and Meisner, M. (2011) \u2018Biomarkers in the critically ill patient: Procalcitonin\u2019, Critical Care Clinics<\/i>, 27(2), pp. 253\u2013263. doi:10.1016\/j.ccc.2011.01.002.<\/p>\n\n